tm
Seeing Is Believing
tm
Seeing Is Believing
TVTX is currently covered by 12 analysts with an average price target of $14.79. This is a potential upside of $8.64 (140.49%) from yesterday's end of day stock price of $6.15.
Travere Therapeutics's activity chart (see below) currently has 45 price targets and 85 ratings on display. The stock rating distribution of TVTX is 87.72% BUY and 12.28% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.32% with an average time for these price targets to be met of 26.29 days.
Highest price target for TVTX is $27, Lowest price target is $9, average price target is $14.79.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 27-Mar-2024.
Currently out of the existing stock ratings of TVTX, 50 are a BUY (87.72%), 7 are a HOLD (12.28%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
18
23 days ago
0/4 (0%)
$10.15 (129.30%)
Buy
17
$10.04 (144.25%)
20
1 months 6 days ago
0/12 (0%)
$8.85 (108.59%)
Buy
13
$6.04 (86.78%)
12
2 months 3 days ago
2/8 (25%)
$4.8 (58.54%)
83
Hold
9
$2.04 (29.31%)
8
2 months 3 days ago
1/2 (50%)
$0.8 (9.76%)
3
Buy
15
$8.04 (115.52%)
25
2 months 25 days ago
0/3 (0%)
$5.85 (63.93%)
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TVTX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?
